Related Experiment Video
Updated: Jun 21, 2026
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Variation of M3 muscarinic receptor expression in different prostate tissues and its significance
Wei Song1, Mingzhen Yuan, Shengtian Zhao
1Department of Minimally Invasive Urology Center, Shandong Provincial Hospital, The Second Hospital of Shandong University, Jinan, China.
Objective:
To detect the expression of the muscarinic receptor (M receptor) in different prostate tissues and analyze the role of its subtype in prostatic oncogenesis.
Methods:
Thirty-six cases of normal prostate and benign prostatic hyperplasia, and 8 cases of prostatic tumor, were used in this study from the Shandong University, Shandong, China, between 2003-2006. The protein expressions of M1, M2, and M3 receptors in each group were determined by Western-blotting. The gene expressions of the M3 receptor and vascular endothelial growth factors (VEGF) in each group were determined by reverse transcriptase-polymerase chain reaction.
Results:
The protein and gene expressions of the M3 receptor in the prostatic carcinoma group were higher than that of benign prostatic hyperplasia group (p=0.0001) and normal prostate group (p=0.0001). The M3 receptor and VEGF showed positive straight-line correlations of gene expressions with the 3 groups (r=0.4999, p=0.0001).
Conclusion:
The M3 receptor may have a close relationship with prostatic oncogenesis.
